Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
04/07/2011 | CA2776170A1 Recombinant c1 .beta.-glucosidase for production of sugars from cellulosic biomass |
04/07/2011 | CA2775938A1 Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose |
04/07/2011 | CA2775685A1 Monoclonal antibody against human hig-1 polypeptide |
04/07/2011 | CA2774916A1 New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody |
04/07/2011 | CA2773842A1 Process for producing cysteine and/or glutathione from cystine employing yeast |
04/06/2011 | EP2305827A1 Cancer antigen MAGE-A9 and uses thereof |
04/06/2011 | EP2305817A2 Anti-IL-12 antibodies, compositions, methods and uses |
04/06/2011 | EP2305808A1 Templated molecules and methods for using such molecules |
04/06/2011 | EP2305804A1 MonoPEGylated human growth hormone |
04/06/2011 | EP2305802A1 Modified vitamin K-dependent polypeptides |
04/06/2011 | EP2305715A2 Monoclonal antibody to osteoprotegerin binding protein |
04/06/2011 | EP2305714A2 Anti-interferon-alpha subtypes antibodies |
04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |
04/06/2011 | EP2305709A1 Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods for use thereof |
04/06/2011 | EP2305704A1 Fucose 1 6-specific lectin |
04/06/2011 | EP2305703A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
04/06/2011 | EP2305702A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
04/06/2011 | EP2305300A1 Pharmaceutical composition for treatment and prevention of cancer |
04/06/2011 | EP2305027A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
04/06/2011 | EP2304439A2 Anti-phospho-akt antibodies |
04/06/2011 | EP2304047A1 Antibodies specific to heterodimers of bcl-2 family and uses thereof |
04/06/2011 | EP2304046A1 Factor viii muteins with reduced immunogenicity |
04/06/2011 | EP2304045A1 Chaperone toolbox |
04/06/2011 | EP1594889B1 Nell peptide expression systems and bone formation activity of nell peptide |
04/06/2011 | EP1529113B1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
04/06/2011 | EP1417237B1 Process for preparation of polypeptides of interest from fusion peolypeptides |
04/06/2011 | EP1407030B1 Methods for large scale production of recombinant dna-derived tpa or k2s molecules |
04/06/2011 | EP1291424B1 Gasc1 gene |
04/06/2011 | CN1953987B Method for construction and use of kluyveromyces lactis promoter variants in k. lactis that substantially lack e. coli transcriptional capability |
04/06/2011 | CN1875095B Recombinant microorganism |
04/06/2011 | CN1836038B Methods for producing secreted polypeptides |
04/06/2011 | CN102007217A Enzymatic conjugation of bioactive moieties |
04/06/2011 | CN102007147A Anti-cd27 antibody |
04/06/2011 | CN102002517A Fermentation medium for preparing recombination IL-1ra (Interleukin-1 Receptor Antagonist) and fermentation method thereof |
04/06/2011 | CN102002510A New streptomyces secretion expression plasmid and application thereof |
04/06/2011 | CN102002503A Fungus resistant plants and their uses |
04/06/2011 | CN102002105A Gene, expression vector, expression method, expression cell and application of human papilloma virus (HPV) 16 E7E6 fusion protein |
04/06/2011 | CN102002102A Body weight modulators, corresponding nucleic acids and proteins, and their use for diagnosis and therapy |
04/06/2011 | CN102002097A Mutant protein capable of being combined with nisin, and coded gene and application thereof |
04/06/2011 | CN102000322A Drug resisting against liver cancer, and preparation and application thereof |
04/06/2011 | CN102000121A Cordyceps militaris oligopeptide composition as well as preparation method and use thereof |
04/06/2011 | CN101565680B Mycoplasma hyopneumoniae P97R1 gene recombined Pichia pastoris and expression protein |
04/06/2011 | CN101220387B Technique for extracting wheatgrass protein polypeptide |
04/06/2011 | CN101215594B Method for preparing pinctada martensii antihypertensive peptide by continuous enzyme membrane reaction |
04/05/2011 | US7919674 Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof |
04/05/2011 | US7919607 Nucleic acids encoding humanized anti-tag 72 CC49 antbodies |
04/05/2011 | US7919606 Biological products |
04/05/2011 | US7919604 Fetal genes |
04/05/2011 | US7919597 Method of producing cell extract for cell-free protein synthesis |
04/05/2011 | US7919595 Antibodies to interferon-like protein Zcyto21(IL29) |
04/05/2011 | US7919594 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders |
04/05/2011 | US7919588 Netrin receptors |
04/05/2011 | US7919329 Method for screening for agents that affect food intake |
04/05/2011 | US7919322 Targeted deletions using retroelement-mediated placement of recombination sites |
04/05/2011 | US7919320 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms ; plants and microorganisms that produce lipids |
04/05/2011 | US7919298 Polypeptides having lipase activity and polynucleotides encoding same |
04/05/2011 | US7919284 L-amino acid producing microorganism and a method for producing an L-amino acid |
04/05/2011 | US7919275 Oxaloacetate hydrolase deficient fungal host cells |
04/05/2011 | US7919274 Detecting position of particle in cell; obtain cell, administer with light emitting fusion protein, detect signal, image signal |
04/05/2011 | US7919273 Structural variants of antibodies for improved therapeutic characteristics |
04/05/2011 | US7919272 Methods and compositions for controlling plant pests |
04/05/2011 | US7919271 Nucleic acid encoding branching enzyme |
04/05/2011 | US7919270 Mammalian expression system |
04/05/2011 | US7919269 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
04/05/2011 | US7919257 Method for selecting a single cell expressing a heterogeneous combination of antibodies |
04/05/2011 | US7919236 G-proteins |
04/05/2011 | US7919098 ErbB-3 based methods and compositions for treating neoplasms |
04/05/2011 | US7919092 Notch receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
04/05/2011 | US7919091 Lipolysis stimulated receptor (LSR) specific antibodies |
04/05/2011 | US7919086 has a higher cell growth-inhibiting activity via an antibody-dependent cell-mediated cytotoxicity (ADCC) activity and a complement-dependent cytotoxicity (CDC) activity |
04/05/2011 | US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL) |
04/05/2011 | CA2455882C Method of protein production in plants |
04/05/2011 | CA2436402C Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies |
04/05/2011 | CA2429027C Antibodies against human receptor h4-1bb |
04/05/2011 | CA2402186C Corynebacterium glutamicum genes encoding metabolic pathway proteins |
04/05/2011 | CA2309355C Tissue cement proteins from rhipicephalus appendiculatus |
04/05/2011 | CA2300854C Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
04/05/2011 | CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
04/05/2011 | CA2229163C Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
03/31/2011 | WO2011037271A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
03/31/2011 | WO2011037227A1 Agent for prevention of atherosclerosis |
03/31/2011 | WO2011036455A1 Bacterial strain for recombinant protein expression, having protease deficient degp retaining chaperone activity, and knocked out tsp and ptr genes |
03/31/2011 | WO2011036454A1 Bacterial host strain |
03/31/2011 | WO2011036174A1 A novel method for the production of a antimicrobial peptide |
03/31/2011 | WO2011035884A1 Process for producing molecules containing specialized glycan structures |
03/31/2011 | WO2011035555A1 Comprehensive process and equipment for use of carbonaceous organic matter |
03/31/2011 | WO2011035492A1 High yield antibiotics producing fungus strain, preparation method and use thereof |
03/31/2011 | WO2010133543A3 Process to produce a wine or fruit juice stabiliser |
03/31/2011 | WO2010030861A3 Compositions and methods for purifying calreticulin |
03/31/2011 | WO2008020333A3 Nucleic acid encoding n-methylputrescine oxidase and uses thereof |
03/31/2011 | US20110078831 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
03/31/2011 | US20110078830 Polypeptides having xylanase activity and polynucleotides encoding same |
03/31/2011 | US20110078829 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
03/31/2011 | US20110077205 Production and Use of Antitumoral Cyclodepsipeptides |